Source: Thrombosis Research. Conference titles: International Conference on Thrombosis and Hemostasis Issues in Cancer. Unidade: IQ
Subjects: ANTICOAGULANTES, ANTINEOPLÁSICOS, BIOQUÍMICA
ABNT
LOBO, Tatiana Correa Carneiro et al. Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris. Thrombosis Research. Oxford: Instituto de Química, Universidade de São Paulo. . Acesso em: 12 nov. 2024. , 2007APA
Lobo, T. C. C., Konig, S., Sogayar, M. C., Francischetti, I. M. B., & Monteiro, R. de Q. (2007). Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris. Thrombosis Research. Oxford: Instituto de Química, Universidade de São Paulo.NLM
Lobo TCC, Konig S, Sogayar MC, Francischetti IMB, Monteiro R de Q. Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris. Thrombosis Research. 2007 ; 120 S165 res. PO-62.[citado 2024 nov. 12 ]Vancouver
Lobo TCC, Konig S, Sogayar MC, Francischetti IMB, Monteiro R de Q. Procoagulant properties of U87MG human glioblastoma cells and molecular targets of the anticoagulant and antitumor agent Ixolaris. Thrombosis Research. 2007 ; 120 S165 res. PO-62.[citado 2024 nov. 12 ]